After delay, FDA approves Novavax’s Covid-19 vaccine, but only for older people and those at high risk

Why did US credit rating get downgraded? How will Trump's tariffs impact Walmart prices? Who is leading JPMorgan's CEO succession race? What caused Nvidia's recent stock drop? Why is Xiaomi investing billions in chip design? How is Biden's cancer diagnosis affecting markets? What are the effects of US-China tariff truce? Why is Qatar Airways posting record profits? How will Moody’s downgrade affect Treasury yields?

After delay, FDA approves Novavax’s Covid-19 vaccine, but only for older people and those at high risk

cnn.com/2025/05/17/health/novavax-covid-vaccine-approval

After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter from the agency, but only for people 65 and older and those 12 and up who have at least one underlying condition that puts them at higher risk of severe…

This story appeared on cnn.com, 2025-05-19 04:47:09.672000.